NEW YORK, March 10, 2023 /PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Read the full report: https://www.reportlinker.com/p04707106/?utm_source=PRN
Global Nanobiotechnology Market to Reach $160.3 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Nanobiotechnology estimated at US$104.8 Billion in the year 2022, is projected to reach a revised size of US$160.3 Billion by 2030, growing at aCAGR of 5.5% over the period 2022-2030. Pharmaceuticals & Biotechnology Industry, one of the segments analyzed in the report, is projected to record 6.3% CAGR and reach US$110.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Medical Devices segment is readjusted to a revised 3.9% CAGR for the next 8-year period.
The U.S. Market is Estimated at $30.6 Billion, While China is Forecast to Grow at 4.8% CAGR
The Nanobiotechnology market in the U.S. is estimated at US$30.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$27.6 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 3.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.
Select Competitors (Total 79 Featured)
- Ablynx NV
- Arrowhead Pharmaceuticals Inc.
- CaPtivate Pharmaceuticals LLC
- Celgene Corporation
- ELITechGroup
- Flamel Technologies SA
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- NanoBio® Corporation
- Nanophase Technologies Corporation
- pSivida Corp.
- Sigma-Aldrich Corp.
- Starpharma Holdings Ltd.
- Vectura Group plc
Read the full report: https://www.reportlinker.com/p04707106/?utm_source=PRN
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
A Curtain Raiser
Recent Market Activity
Nanobiotechnology - The Next Big Thing
An Insight into the Global Nanobiotechnology Market
Major Market Drivers
Where Conventional Molecular Science Falls Short Nanobio Steps In
Nanotechnology Revolutionizes Pharmaceuticals & Healthcare Sector
Nanomedicine Market to Achieve Phenomenal Growth
Opportunities Galore for Nanomedicine
Drug Delivery - A Promising Application Area for Nanotechnology
Nanotechnology Offers Huge Potential in Brain Disorder Treatment
High Demand for Nanobots and Nano Healthcare Devices
Nanotechnology Gaining Prominence for Treatment of Cancer
Nanotechnology in Drug Delivery: A Specialized Market Opportunity
Commercialization of Nanotechnology-based Medical Products
Gains Momentum
Nanodiagnostic Products to Witness Strong Demand Growth
Dendrimers Serve as a Base to Build Multifunctional Nanodevices
Nanotechnology Rescues Poor Water Soluble Drugs from Abandonment
Huge Opportunities for Nanomaterials in the Medical Field
Commercial Opportunities in Healthcare Sector
Future Possibilities
Global Market for Fullerenes - An Insight
Dawn Breaks on Nanobiotechnology
Demystifying the Intriguing World of Nanobiotech
A Meeting Place of Medicine?s Best Solutions
Nanobiotechnology to Become Viable for All Drug Development Stages
Nanoparticles: The Foundation of Nanobiotechnology
Improved Optical Properties and Stability of Nanoparticles
Nanoemulsions
The Promise of Nanobiotechnology
Biological Weaponries against Diseases Come in Small Packages
Proffered Benefits of Nanobiotechnology
Opportunity & Beyond
Nanobiotechnology - Will it Live Up to the Expectations?
The Future of Nanobiotechnology: Shape of Things to Come
Nanobiotechnology: The Outer Limits
Futuristics: A Rumination
Conclusions
Nanobiotechnology - Global Key Competitors Percentage Market
Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
Ablynx NV (Belgium)
Arrowhead Pharmaceuticals, Inc. (USA)
Avadel Pharmaceuticals plc (Ireland)
CaPtivate Pharmaceuticals LLC (USA)
Celgene Corporation (USA)
ELITechGroup (France)
GlaxoSmithKline Plc. (UK)
Johnson & Johnson (USA)
Merck & Co., Inc. (USA)
NanoBio® Corporation (USA)
Nanophase Technologies Corporation (USA)
pSivida Corp. (USA)
Sigma-Aldrich Corp. (USA)
Starpharma Holdings Ltd. (Australia)
Vectura Group plc (UK)
3. MARKET TRENDS & DRIVERS
Present Status and Future Opportunities
Outlook
Developing Countries to Rise over the Horizon
Nanomaterials & Nanoparticles Witness Robust Activity
Focus on Improved Performance to Bring New Manufacturing
Methods for Nanomaterials
Why Invest in Nanobiotechnology?
Private and Public Companies to Step Up Funding on Nanotechnology
United States Lead the Way in Government Funding
Increasing Awareness on Technology to Drive Growth
Demand for Novel Products to Push Up Growth
Nano-Enabled Drug Discovery Holds Tremendous Potential
Consolidation Sharpens the Industry's Edge
The Regulatory Framework Evolves with the Technology
Quantum Dot Patents Pose Legal Tangles
Miniaturized Liquid Handling Becomes Progressive
Trends in Nanotechnology Enabled Drug Delivery Systems
Patent Expiries: A Key Driver
Nanotechnology Enabled Drug Delivery to Exhume Unused Drugs
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Nanobiotechnology by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 2: World Historic Review for Nanobiotechnology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 3: World 16-Year Perspective for Nanobiotechnology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for
Pharmaceuticals & Biotechnology Industry by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Pharmaceuticals &
Biotechnology Industry by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 6: World 16-Year Perspective for Pharmaceuticals &
Biotechnology Industry by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for
Medical Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 8: World Historic Review for Medical Devices by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 9: World 16-Year Perspective for Medical Devices by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
Table 10: World Nanobiotechnology Market Analysis of Annual
Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2023 (E)
Table 11: USA Recent Past, Current & Future Analysis for
Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology
Industry and Medical Devices - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 12: USA Historic Review for Nanobiotechnology by End-Use -
Pharmaceuticals & Biotechnology Industry and Medical Devices
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 13: USA 16-Year Perspective for Nanobiotechnology by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceuticals & Biotechnology Industry and Medical Devices
for the Years 2014, 2023 & 2030
CANADA
Table 14: Canada Recent Past, Current & Future Analysis for
Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology
Industry and Medical Devices - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 15: Canada Historic Review for Nanobiotechnology by
End-Use - Pharmaceuticals & Biotechnology Industry and Medical
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 16: Canada 16-Year Perspective for Nanobiotechnology by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceuticals & Biotechnology Industry and Medical Devices
for the Years 2014, 2023 & 2030
JAPAN
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2023 (E)
Table 17: Japan Recent Past, Current & Future Analysis for
Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology
Industry and Medical Devices - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 18: Japan Historic Review for Nanobiotechnology by
End-Use - Pharmaceuticals & Biotechnology Industry and Medical
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 19: Japan 16-Year Perspective for Nanobiotechnology by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceuticals & Biotechnology Industry and Medical Devices
for the Years 2014, 2023 & 2030
CHINA
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2023 (E)
Table 20: China Recent Past, Current & Future Analysis for
Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology
Industry and Medical Devices - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 21: China Historic Review for Nanobiotechnology by
End-Use - Pharmaceuticals & Biotechnology Industry and Medical
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 22: China 16-Year Perspective for Nanobiotechnology by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceuticals & Biotechnology Industry and Medical Devices
for the Years 2014, 2023 & 2030
EUROPE
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2023 (E)
Table 23: Europe Recent Past, Current & Future Analysis for
Nanobiotechnology by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2022 through 2030 and %
CAGR
Table 24: Europe Historic Review for Nanobiotechnology by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 25: Europe 16-Year Perspective for Nanobiotechnology by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2014, 2023 & 2030
Table 26: Europe Recent Past, Current & Future Analysis for
Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology
Industry and Medical Devices - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 27: Europe Historic Review for Nanobiotechnology by
End-Use - Pharmaceuticals & Biotechnology Industry and Medical
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 28: Europe 16-Year Perspective for Nanobiotechnology by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceuticals & Biotechnology Industry and Medical Devices
for the Years 2014, 2023 & 2030
FRANCE
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2023 (E)
Table 29: France Recent Past, Current & Future Analysis for
Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology
Industry and Medical Devices - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 30: France Historic Review for Nanobiotechnology by
End-Use - Pharmaceuticals & Biotechnology Industry and Medical
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 31: France 16-Year Perspective for Nanobiotechnology by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceuticals & Biotechnology Industry and Medical Devices
for the Years 2014, 2023 & 2030
GERMANY
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Germany for 2023 (E)
Table 32: Germany Recent Past, Current & Future Analysis for
Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology
Industry and Medical Devices - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 33: Germany Historic Review for Nanobiotechnology by
End-Use - Pharmaceuticals & Biotechnology Industry and Medical
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 34: Germany 16-Year Perspective for Nanobiotechnology by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceuticals & Biotechnology Industry and Medical Devices
for the Years 2014, 2023 & 2030
ITALY
Table 35: Italy Recent Past, Current & Future Analysis for
Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology
Industry and Medical Devices - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 36: Italy Historic Review for Nanobiotechnology by
End-Use - Pharmaceuticals & Biotechnology Industry and Medical
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 37: Italy 16-Year Perspective for Nanobiotechnology by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceuticals & Biotechnology Industry and Medical Devices
for the Years 2014, 2023 & 2030
UNITED KINGDOM
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United Kingdom for 2023 (E)
Table 38: UK Recent Past, Current & Future Analysis for
Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology
Industry and Medical Devices - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 39: UK Historic Review for Nanobiotechnology by End-Use -
Pharmaceuticals & Biotechnology Industry and Medical Devices
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 40: UK 16-Year Perspective for Nanobiotechnology by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceuticals & Biotechnology Industry and Medical Devices
for the Years 2014, 2023 & 2030
REST OF EUROPE
Table 41: Rest of Europe Recent Past, Current & Future Analysis
for Nanobiotechnology by End-Use - Pharmaceuticals &
Biotechnology Industry and Medical Devices - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 42: Rest of Europe Historic Review for Nanobiotechnology
by End-Use - Pharmaceuticals & Biotechnology Industry and
Medical Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR
Table 43: Rest of Europe 16-Year Perspective for
Nanobiotechnology by End-Use - Percentage Breakdown of Value
Sales for Pharmaceuticals & Biotechnology Industry and Medical
Devices for the Years 2014, 2023 & 2030
ASIA-PACIFIC
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Asia-Pacific for 2023 (E)
Table 44: Asia-Pacific Recent Past, Current & Future Analysis
for Nanobiotechnology by End-Use - Pharmaceuticals &
Biotechnology Industry and Medical Devices - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 45: Asia-Pacific Historic Review for Nanobiotechnology by
End-Use - Pharmaceuticals & Biotechnology Industry and Medical
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 46: Asia-Pacific 16-Year Perspective for
Nanobiotechnology by End-Use - Percentage Breakdown of Value
Sales for Pharmaceuticals & Biotechnology Industry and Medical
Devices for the Years 2014, 2023 & 2030
REST OF WORLD
Table 47: Rest of World Recent Past, Current & Future Analysis
for Nanobiotechnology by End-Use - Pharmaceuticals &
Biotechnology Industry and Medical Devices - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 48: Rest of World Historic Review for Nanobiotechnology
by End-Use - Pharmaceuticals & Biotechnology Industry and
Medical Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR
Table 49: Rest of World 16-Year Perspective for
Nanobiotechnology by End-Use - Percentage Breakdown of Value
Sales for Pharmaceuticals & Biotechnology Industry and Medical
Devices for the Years 2014, 2023 & 2030
IV. COMPETITION
Read the full report: https://www.reportlinker.com/p04707106/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
View original content to download multimedia:https://www.prnewswire.com/news-releases/global-nanobiotechnology-market-to-reach-160-3-billion-by-2030--301768136.html
SOURCE Reportlinker
